Get the Stockscreener App
3.83
3.51%
+0.13
Relmada Therapeutics Inc Stock (RLMD) Forecast
The Relmada Therapeutics Inc (RLMD) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.2146, representing a -42.18% decrease from the current price of $3.83. The highest analyst price target is $4.4216, and the lowest is $0.00758.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RLMD Price Target
Average 6.5128
(+70.05% Upside)
Is Relmada Therapeutics Inc (RLMD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.19 | Neutral |
| STOCH(9,6) | 12.64 | Buy |
| STOCHRSI(14) | 26.21 | Neutral |
| MACD(12,26) | -0.3322 | Sell |
| ADX(14) | 33.40 | Sell |
| William %R | -85.71 | Buy |
| CCI(14) | -97.20 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.116
Sell
|
4.0653
Sell
|
| MA20 |
4.4225
Sell
|
4.3435
Sell
|
| MA50 |
5.1188
Sell
|
4.6256
Sell
|
| MA100 |
4.3638
Sell
|
4.4103
Sell
|
| MA200 |
3.6882
Buy
|
3.983
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, RLMD could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on RLMD, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 35.19 indicates that RLMD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.64 indicates that RLMD is oversold. This indicates that RLMD price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 26.21 indicates that RLMD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.4 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -97.2 indicates that RLMD is still oversold but not to an extreme extent.
Long-term RLMD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Relmada Therapeutics Inc financial reports and earnings history, Relmada Therapeutics Inc (RLMD) stock could reach $14.73 by 2030, $125.29 by 2040 and $84.19 by 2050. See the projected annual prices until 2050 of the Relmada Therapeutics Inc stock below:
- Relmada Therapeutics Inc (RLMD) is expected to reach an average price of $23.11 in 2035, with a high prediction of $25.70 and a low estimate of $23.96. This indicates an $503.45% rise from the last recorded price of $3.83.
- Relmada Therapeutics Inc (RLMD) stock is projected to chart a bullish course in 2040, with an average price target of $121.95, representing an $3,084% surge from its current level. The forecast ranges from a conservative $123.90 to a sky-high $125.29.
- Our analysts predict Relmada Therapeutics Inc (RLMD) to jump 2,852% by 2045, soaring from $115.49 to an average price of $113.04, potentially reaching $121.19. While $115.49 is the low estimate, the potential upside is significant.
- Relmada Therapeutics Inc (RLMD) stock is expected to climb by 2050, reaching an average of $76.54, a $1,898% jump from its current level. However, a wide range of estimates exists, with high and low targets of $84.19 and $77.77, respectively, highlighting the market's uncertainty.
Relmada Therapeutics Inc Stock (RLMD) Year by Year Forecast
Relmada Therapeutics Inc Stock (RLMD) Price Forecast for 2024
Our forecast for RLMD stock price in 2024 now indicates an average price target of $6.5128 with a high forecast of $13.02 and a low forecast of $0.00758. The average prediction reflects an increase of +70.05% from the last recorded price of $3.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $1.4476 | $0.00758 | $4.4216 | -62.20% |
| June, 2024 | $4.319 | $0.7629 | $6.374 | +12.77% |
| July, 2024 | $5.5157 | $0.4903 | $6.0207 | +44.01% |
| August, 2024 | $4.5571 | $1.5617 | $9.9009 | +18.98% |
| September, 2024 | $8.1638 | $2.8984 | $9.7078 | +113.15% |
| October, 2024 | $8.7652 | $2.8933 | $8.7752 | +128.86% |
| November, 2024 | $11.30 | $5.6312 | $12.74 | +194.95% |
| December, 2024 | $3.6433 | $2.2233 | $13.02 | -4.88% |
Relmada Therapeutics Inc Stock (RLMD) Price Forecast for 2025
Relmada Therapeutics Inc Stock (RLMD) is expected to reach an average price of $6.2012 in 2025, with a high prediction of $12.38 and a low estimate of $0.0215. This indicates an +61.91% rise from the last recorded price of $3.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $6.1447 | $2.8386 | $8.8993 | +60.43% |
| February, 2025 | $0.656 | $0.046 | $9.9507 | -82.87% |
| March, 2025 | $0.2772 | $1.6333 | $9.4014 | -92.76% |
| April, 2025 | $3.7141 | $0.2189 | $4.6541 | -3.03% |
| May, 2025 | $2.8555 | $1.8955 | $6.1197 | -25.44% |
| June, 2025 | $0.3722 | $0.0215 | $4.8072 | -90.28% |
| July, 2025 | $4.8964 | $2.4824 | $3.5464 | +27.84% |
| August, 2025 | $1.325 | $0.4135 | $2.1196 | -65.40% |
| September, 2025 | $2.0383 | $0.2697 | $2.8303 | -46.78% |
| October, 2025 | $0.7431 | $1.7969 | $1.6729 | -80.60% |
| November, 2025 | $4.8945 | $0.2938 | $6.2545 | +27.79% |
| December, 2025 | $7.6212 | $2.7298 | $12.38 | +98.99% |
Relmada Therapeutics Inc Stock (RLMD) Price Forecast for 2026
The predicted value for Relmada Therapeutics Inc (RLMD) in 2026 is set at an average of $12.29. Estimates vary from a peak of $24.47 to a trough of $0.1126, indicating an +220.86% surge from the present price of $3.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.0126 | $0.1126 | $8.3365 | -47.45% |
| February, 2026 | $2.224 | $0.5333 | $5.0479 | -41.93% |
| March, 2026 | $1.9107 | $0.3693 | $3.4503 | -50.11% |
| April, 2026 | $9.8321 | $1.946 | $10.42 | +156.71% |
| May, 2026 | $14.34 | $8.5974 | $18.67 | +274.50% |
| June, 2026 | $17.53 | $12.78 | $20.16 | +357.71% |
| July, 2026 | $6.7385 | $7.6285 | $24.47 | +75.94% |
| August, 2026 | $7.0317 | $7.0578 | $6.6378 | +83.60% |
| September, 2026 | $9.6704 | $7.6964 | $7.6904 | +152.49% |
| October, 2026 | $8.439 | $8.694 | $8.6297 | +120.34% |
| November, 2026 | $6.8323 | $6.9523 | $7.1737 | +78.39% |
| December, 2026 | $6.7309 | $6.9909 | $6.8562 | +75.74% |
Relmada Therapeutics Inc Stock (RLMD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Relmada Therapeutics Inc (RLMD) is $14.44, with a high forecast of $28.44 and a low forecast of $0.4443. This indicates an +277.08% increase from the last price of $3.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.4395 | $6.9255 | $7.1395 | +94.24% |
| February, 2027 | $6.4481 | $6.5681 | $6.9891 | +68.36% |
| March, 2027 | $5.3714 | $5.5867 | $6.1528 | +40.25% |
| April, 2027 | $5.09 | $5.27 | $5.1218 | +32.90% |
| May, 2027 | $4.0233 | $4.1833 | $4.7393 | +5.05% |
| June, 2027 | $3.1919 | $3.8119 | $3.8579 | -16.66% |
| July, 2027 | $1.8805 | $2.2055 | $2.6712 | -50.90% |
| August, 2027 | $1.8538 | $1.9738 | $1.8098 | -51.60% |
| September, 2027 | $1.2824 | $1.4224 | $1.2024 | -66.52% |
| October, 2027 | $0.751 | $0.851 | $0.8071 | -80.39% |
| November, 2027 | $0.6224 | $0.4443 | $0.8005 | -83.75% |
| December, 2027 | $26.18 | $26.70 | $28.44 | +583.50% |
Relmada Therapeutics Inc Stock (RLMD) Price Forecast for 2028
In 2028, Relmada Therapeutics Inc (RLMD) is projected to reach an average price of $24.13, with a high projection of $30.34 and a low estimate of $17.92. This indicates an +530.02% rise from the last price of $3.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $27.88 | $29.46 | $29.57 | +628.05% |
| February, 2028 | $29.47 | $31.09 | $30.34 | +669.50% |
| March, 2028 | $25.25 | $27.20 | $26.13 | +559.24% |
| April, 2028 | $32.30 | $26.59 | $29.71 | +743.24% |
| May, 2028 | $26.11 | $26.97 | $28.80 | +581.80% |
| June, 2028 | $28.31 | $27.79 | $26.44 | +639.16% |
| July, 2028 | $26.20 | $24.49 | $27.45 | +583.98% |
| August, 2028 | $24.29 | $23.44 | $23.28 | +534.30% |
| September, 2028 | $23.47 | $22.50 | $22.76 | +512.82% |
| October, 2028 | $18.00 | $20.34 | $20.69 | +369.91% |
| November, 2028 | $15.68 | $17.92 | $17.60 | +309.53% |
| December, 2028 | $21.45 | $18.78 | $20.25 | +460.11% |
Relmada Therapeutics Inc Stock (RLMD) Price Forecast for 2029
The 2029 price forecast for Relmada Therapeutics Inc Stock (RLMD) is $17.90 on average, with a high prediction of $25.37 and a low estimate of $10.43. This represents an +367.39% increase from the previous price of $3.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $19.63 | $19.39 | $17.73 | +412.50% |
| February, 2029 | $26.71 | $25.20 | $25.26 | +597.28% |
| March, 2029 | $23.91 | $25.03 | $24.90 | +524.36% |
| April, 2029 | $20.16 | $20.72 | $21.36 | +426.36% |
| May, 2029 | $22.13 | $21.33 | $21.14 | +477.73% |
| June, 2029 | $25.44 | $21.87 | $23.88 | +564.34% |
| July, 2029 | $20.47 | $23.94 | $25.37 | +434.48% |
| August, 2029 | $22.91 | $21.32 | $21.48 | +498.12% |
| September, 2029 | $21.76 | $23.34 | $22.34 | +468.02% |
| October, 2029 | $16.44 | $18.20 | $19.14 | +329.29% |
| November, 2029 | $8.039 | $10.43 | $12.93 | +109.90% |
| December, 2029 | $14.66 | $10.99 | $10.51 | +282.65% |
Relmada Therapeutics Inc Stock (RLMD) Price Forecast for 2030
Relmada Therapeutics Inc Stock (RLMD) is expected to reach an average price of $10.38 in 2030, with a high forecast of $20.67 and a low forecast of $0.0897. This signifies an +171.01% surge from the last price of $3.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $15.85 | $15.56 | $14.73 | +313.91% |
| February, 2030 | $13.75 | $15.42 | $15.01 | +259.01% |
| March, 2030 | $9.7273 | $13.94 | $13.83 | +153.98% |
| April, 2030 | $1.5938 | $3.3138 | $6.9466 | -58.39% |
| May, 2030 | $2.5289 | $0.2689 | $3.5269 | -33.97% |
| June, 2030 | $6.1217 | $0.0897 | $10.25 | +59.84% |
| July, 2030 | $20.20 | $20.43 | $20.08 | +427.54% |
| August, 2030 | $20.67 | $20.32 | $19.88 | +439.74% |
| September, 2030 | $20.28 | $20.67 | $20.67 | +429.47% |
| October, 2030 | $18.41 | $18.43 | $19.87 | +380.57% |
| November, 2030 | $17.61 | $17.75 | $17.91 | +359.87% |
| December, 2030 | $17.26 | $17.10 | $17.34 | +350.64% |
1.53%
3.38%
Cap:
|
Volume (24h):